DCF — HALIFAX MEDICAL CENTER
Enterprise Value: $-417.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-417.5M
Enterprise Value
$-143.0M
PV of Cash Flows
$-274.5M
PV of Terminal Value
$-442.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $584.9M | $-20.1M | -3.0% | $-44.8M | $-40.8M |
| Year 2 | $602.4M | $-14.6M | -2.0% | $-40.1M | $-33.2M |
| Year 3 | $620.5M | $-8.9M | -1.0% | $-35.1M | $-26.4M |
| Year 4 | $639.1M | $-6.0M | -1.0% | $-33.0M | $-22.5M |
| Year 5 | $658.3M | $-4.5M | -1.0% | $-32.4M | $-20.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-417.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$567.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03931581786871593
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5